Dynorphin A Boosts Immune Cell Engulfing Ability Through a Non-Opioid Mechanism
Dynorphin A dose-dependently enhanced macrophage phagocytosis through a naloxone-insensitive mechanism, while enkephalins and other peptides had no effect.
Quick Facts
What This Study Found
Dynorphin A dose-dependently enhanced macrophage phagocytosis through a naloxone-insensitive (non-opioid receptor) mechanism.
Key Numbers
How They Did This
Mouse peritoneal macrophage phagocytosis was measured by flow cytometry after treatment with dynorphin A and related peptides. Naloxone was used to test opioid receptor involvement.
Why This Research Matters
Dynorphin A has immune-boosting effects beyond its known role in pain. The non-opioid mechanism means these immune effects could potentially be harnessed without triggering opioid side effects.
The Bigger Picture
Dynorphin A has immune-boosting effects through a non-opioid mechanism. This means it could potentially be developed as an immune enhancer without causing the pain, mood, or addiction effects associated with opioid receptor activation.
What This Study Doesn't Tell Us
In vitro study using mouse macrophages. The non-opioid mechanism is not identified. Whether this effect occurs in living animals is unknown.
Questions This Raises
- ?What non-opioid receptor mediates dynorphin's phagocytosis enhancement?
- ?Could dynorphin-based drugs boost immunity in immunocompromised patients?
Trust & Context
- Key Stat:
- Non-opioid immune boost Dynorphin A enhanced phagocytosis through a naloxone-insensitive mechanism — immune benefits without opioid receptor activation
- Evidence Grade:
- Preliminary — in vitro study with flow cytometry. Non-opioid mechanism not identified.
- Study Age:
- Published in 1995 (31 years ago). Non-opioid actions of dynorphin continue to be studied.
- Original Title:
- Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.
- Published In:
- Journal of neuroimmunology, 60(1-2), 37-43 (1995)
- Authors:
- Ichinose, M, Asai, M, Sawada, M
- Database ID:
- RPEP-00323
Evidence Hierarchy
Frequently Asked Questions
How does dynorphin boost immunity?
Dynorphin A enhances macrophages' ability to engulf and destroy pathogens through a mechanism that doesn't involve opioid receptors. The specific receptor or signaling pathway is not yet identified.
Could this be developed into a drug?
Potentially. Since the immune-boosting effect doesn't require opioid receptor activation, a dynorphin-based drug could enhance immunity without causing pain, mood, or addiction-related side effects.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00323APA
Ichinose, M; Asai, M; Sawada, M. (1995). Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.. Journal of neuroimmunology, 60(1-2), 37-43.
MLA
Ichinose, M, et al. "Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.." Journal of neuroimmunology, 1995.
RethinkPeptides
RethinkPeptides Research Database. "Enhancement of phagocytosis by dynorphin A in mouse peritone..." RPEP-00323. Retrieved from https://rethinkpeptides.com/research/ichinose-1995-enhancement-of-phagocytosis-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.